MedTrace Logo

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

NCT00393354 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 325

Last updated 2022-02-18

No results posted yet for this study

Summary

Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.

Conditions

  • Recurrent Low Back Pain

Interventions

DRUG

MK0663, Etoricoxib / Duration of Treatment : 12 Weeks

DRUG

Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-04-30
Primary Completion
2000-11-30
Completion
2000-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00393354 on ClinicalTrials.gov